Soligenix Inc. Advances Treatment for Rare Behçet’s Disease with SGX945
Behçet’s disease, a rare autoimmune condition with prevalence estimates varying from 0.12 to 7.5 per 100,000 in the United States and Europe, presents significant challenges for those affected. The disease,...